Benitec Biopharma Inc. (BNTC) income statement
BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.92−0.23 (-2.76%)
Close on Nov 20, 2026Market cap $276.10MP/E –Yield –
Benitec Biopharma Inc. financial ratios
See a number that looks wrong?